Publications by authors named "Merry Tetef"

Claim this Profile
E
ER-Targeted PET for Initial Staging and Suspected Recurrence in ER-Positive Breast Cancer.
Gary A Ulaner, Mel Silverstein, Chaitali Nangia, Merry Tetef, Louis Vandermolen

JAMA Netw Open· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tolerability of Breast Radiation Therapy in the Setting of Mondor Disease.
Kevin Lin, Heather R MacDonald, Merry L Tetef, Colleen L Coleman

Adv Radiat Oncol· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase II randomized trial of a non-steroidal mouth wash for prevention and treatment of stomatitis in women with hormone receptor positive breast cancer treated with everolimus.
Parvin F Peddi, Merry Tetef, Paul Coluzzi, Karo K Arzoo, Eddie H Hu

Ther Adv Med Oncol· November 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase II studies of gemcitabine and cisplatin in heavily and minimally pretreated metastatic breast cancer.
Helen K Chew, James H Doroshow, Paul Frankel, Kim A Margolin, George Somlo, Merry L Tetef

J Clin Oncol· May 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase I trial of intraperitoneal gemcitabine in the treatment of advanced malignancies primarily confined to the peritoneal cavity.
Robert J Morgan, Timothy W Synold, Bixin Xi, Dean Lim, Stephen Shibata, Merry Tetef

Clin Cancer Res· February 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase II trial of carboplatin and infusional cyclosporine in platinum-resistant recurrent ovarian cancer.
Robert J Morgan, Timothy W Synold, David Gandara, Franco Muggia, Sidney Scudder, Merry Tetef

Cancer Chemother Pharmacol· October 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Feasibility and pharmacokinetic study of infusional dexrazoxane and dose-intensive doxorubicin administered concurrently over 96 h for the treatment of advanced malignancies.
Warren A Chow, Timothy W Synold, Merry L Tetef, Jeffrey Longmate, Paul Frankel

Cancer Chemother Pharmacol· September 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase I study of cisdiamminedichloroplatinum in combination with azidothymidine in the treatment of patients with advanced malignancies.
Robert J Morgan, Edward M Newman, Lawrence Sowers, Kevin Scanlon, Jonathan Harrison, Merry Tetef

Cancer Chemother Pharmacol· June 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis